Doctor Massimiliano Camilli
Catholic University of the Sacred Heart, Rome (Italy)
Member of:
/f/125658/5000x1496/8aa45c8224/eacvi-acronym-text-rgb.png)
/f/125658/3386x1417/951de003e4/hfa-acronym-name-rgb.png)
Effects of sacubitril/valsartan on atrial function and structure as treatment response indicators in patients with heart failure with reduced ejection fraction: an observational prospective study.
Event: Heart Failure 2023
Topic: Imaging
Session: Chronic heart failure - imaging 1
Cancer incidence and mortality in patients diagnosed with heart failure: results from an updated systematic review and meta-analysis.
Event: Heart Failure 2023
Topic: Cardiotoxicity of Drugs and Other Therapies
Session: ePosters in chronic heart failure - pathophysiology and mechanisms 2
Effects of sacubitril/valsartan on atrial function and structure as treatment response indicators in patients with heart failure with reduced ejection fraction: an observational prospective study.
Event: EACVI 2023
Topic: Systolic and Diastolic Function
Session: Atrial Size and Function 2
Advanced echocardiographic features, three-dimensional Left Ventricular-Arterial Coupling and vascular function in childhood cancer survivors exposed to anthracycline chemotherapy
Event: Heart Failure 2022
Topic: Cardio-Oncology
Session: Heart Failure ePosters - focus on Comorbidities and special population
Long-term exposure to ambient air pollution portends a higher risk of coronary plaque vulnerability and instability in patients with acute coronary syndrome: an optical coherence tomography study.
Event: ESC Congress 2021 - The Digital Experience
Topic: Vulnerable Plaque
Session: Acute Coronary Syndromes ePosters
Efficacy of sodium-glucose cotransporter-2 inhibitors in heart failure patients treated with dual angiotensin receptor blocker-neprilysin inhibitor: an updated meta-analysis.
Event: Heart Failure 2021
Topic: Antidiabetic Pharmacotherapy
Session: ePoster session
